Xing Mengen, Song Weihong
Center for Geriatric Medicine, International Center for Alzheimer's Research, Prevention and Treatment, The First Affiliated Hospital and Oujiang Laboratory; Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, Zhejiang, China.
State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Science. 2025 Aug 7;389(6760):571-572. doi: 10.1126/science.adz8959.
A modified antibody targeting amyloid-β reduces adverse events and increases efficacy in a mouse model.
一种靶向β淀粉样蛋白的改良抗体可减少小鼠模型中的不良事件并提高疗效。
